Redox-sensitive targeted nanoparticles synthesized from heparin mimetics for potential glioma treatment application
Glioblastoma (GBM) is a highly aggressive primary brain tumor with a median survival of less than 15 months following standard treatments, largely due to obstacles such as the blood–brain barrier (BBB) and tumor heterogeneity. To overcome these challenges, we developed a redox-sensitive, targeted na...
Saved in:
| Main Authors: | Yang Yang, Jie Zhang, Yuanpin Min, Wendi Zhou, Guozhong Lv |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Carbohydrate Polymer Technologies and Applications |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666893925002026 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heparin, Heparin-like Molecules, and Heparin Mimetics in Breast Cancer: A Concise Review
by: Diego R. Gatica Portillo, et al.
Published: (2025-07-01) -
Maculopathy after long-term use of fondaparinux, a heparin mimetic and heparanase inhibitor
by: Benjamin R. Lin, et al.
Published: (2025-06-01) -
Application of Multifunctional Metal Nanoparticles in the Treatment of Glioma
by: Ren Y, et al.
Published: (2025-01-01) -
Efficacy of topical heparin spray on donor site wound healing after split thickness skin grafting
by: Faraz Adil, et al.
Published: (2025-07-01) -
Mimetic set and match: Around Shaffer’s “Sleuth”
by: Andrzej Fretschel-Hojarski
Published: (2025-04-01)